found that SMAD3 activation in neutrophil TANs was associated with increased N2 phenotype and poor prognosis of NSCLC, while SMAD3 inhibition promoted the polarization of TANs to the anti-tumor N1 phenotype, thereby inhibiting the development of lung cancer33. The gene discussed is SMAD3; the disease is non-small cell lung carcinoma.